Medications for the treatment of opioid use disorder (MOUD) such as buprenorphine are the most effective treatment available for OUD. Beyond drug testing results and retention in care, systematically measured clinical outcomes to assess clinical success of treatment have proven elusive. There is growing interest in integrating systematic monitoring of patient-reported outcomes and measurement-based care as strategies to improve patients' success in treatment. "Recovery capital" is a theoretical construct that represents personal, social, environmental, and cultural resources that can help individuals initiate and sustain recovery from a substance use disorder (SUD). The objective of the present study was to characterize changes in recovery capital assessed via the Brief Assessment of Recovery Capital (BARC-10) from baseline as well as the association between baseline scores and retention among patients receiving treatment with buprenorphine in a telehealth setting.
Continuing Medical Education (CME) Credits Available
Participants in this program may earn the following CME credits:
✔ 1 AOA Category 1-A Credit✔ 1 AMA PRA Category 1 Credit™✔ 1 AAPA Category 1 CME Credit ✔ 1 Nurses CNE Credit
Earn valuable continuing education credits while enhancing your professional knowledge!